Abstract
Abdominal aortic aneurysm (AAA) is a devastating disease associated with high prevalence of death due to aortic rupture. Currently the therapy is restricted to surgical procedures to prevent aortic rupture, which in turn has a risk for postoperative mortality. There are no proven pharmacological therapies available to prevent expansion or rupture of AAA due to the paucity of knowledge on the mechanisms underlying the nature and pathophysiological processes of this complex disease. Animal models are powerful tools to provide mechanistic insights into understanding the development of AAA. Numerous pharmacological approaches have been explored as potential therapies in experimental AAA in the past decade. This review overviews recent advances in mechanistic studies of AAA in angiotensin II-infused mouse models and highlights their clinical relevance for possible therapeutic targets.
Keywords: Abdominal aortic aneurysms, mechanisms, angiotensin, inflammation, mouse.
Current Pharmaceutical Design
Title:Angiotensin II and Abdominal Aortic Aneurysms: An update
Volume: 21 Issue: 28
Author(s): Jing Liu, Alan Daugherty and Hong Lu
Affiliation:
Keywords: Abdominal aortic aneurysms, mechanisms, angiotensin, inflammation, mouse.
Abstract: Abdominal aortic aneurysm (AAA) is a devastating disease associated with high prevalence of death due to aortic rupture. Currently the therapy is restricted to surgical procedures to prevent aortic rupture, which in turn has a risk for postoperative mortality. There are no proven pharmacological therapies available to prevent expansion or rupture of AAA due to the paucity of knowledge on the mechanisms underlying the nature and pathophysiological processes of this complex disease. Animal models are powerful tools to provide mechanistic insights into understanding the development of AAA. Numerous pharmacological approaches have been explored as potential therapies in experimental AAA in the past decade. This review overviews recent advances in mechanistic studies of AAA in angiotensin II-infused mouse models and highlights their clinical relevance for possible therapeutic targets.
Export Options
About this article
Cite this article as:
Liu Jing, Daugherty Alan and Lu Hong, Angiotensin II and Abdominal Aortic Aneurysms: An update , Current Pharmaceutical Design 2015; 21 (28) . https://dx.doi.org/10.2174/1381612821666150826093318
DOI https://dx.doi.org/10.2174/1381612821666150826093318 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy
Current Medicinal Chemistry CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia
Central Nervous System Agents in Medicinal Chemistry Endoplasmic Reticulum Stress in Arterial Smooth Muscle Cells: A Novel Regulator of Vascular Disease
Current Cardiology Reviews Vascular microRNAs
Current Drug Targets Pediatric Chronic Daily Headache
Current Pediatric Reviews Homocysteine in Neurology: From Endothelium to Neurodegeneration
Current Nutrition & Food Science Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives
Current Drug Targets All for Statins and Statins for All; An Update
Current Pharmaceutical Design Statins Exert Multiple Beneficial Effects on Patients Undergoing Percutaneous Revascularization Procedures
Current Drug Targets Hepatocyte Growth Factor and Insulin-like Growth Factor-1 based Cellular Therapies for Oxidative Stress Injury
Current Stem Cell Research & Therapy Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Evaluation of Pharmacological Treatment Strategies in Traumatic Brain Injury
Current Pharmaceutical Design Gadolinium-based Imaging Contrast Agents
Current Medical Imaging Coarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews New Insights into the Biology of 1-Antitrypsin and its Role in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Safety Analysis and Improved Cardiac Function Following Local Autologous Transplantation of CD133+ Enriched Bone Marrow Cells After Myocardial Infarction
Current Neurovascular Research 3D Printing in Modern Cardiology
Current Pharmaceutical Design A Case of Pulmonary Tuberculosis Mimicking as Diffuse Alveolar Hemorrhage: A Case Report
New Emirates Medical Journal A Review of Artificial Intelligence in Cerebrovascular Disease Imaging: Applications and Challenges
Current Neuropharmacology